Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Reducing analytical variation between point-of-care and laboratory HbA1c testing.

Malkani S, Korpi-Steiner N, Rao LV.

J Diabetes. 2013 Jun;5(2):192-6. doi: 10.1111/1753-0407.12009.

PMID:
23035661
2.

Evaluation of two HbA1c point-of-care analyzers.

Sánchez-Mora C, S Rodríguez-Oliva M, Fernández-Riejos P, Mateo J, Polo-Padillo J, Goberna R, Sánchez-Margalet V.

Clin Chem Lab Med. 2011 Apr;49(4):653-7. doi: 10.1515/CCLM.2011.101. Epub 2011 Feb 17.

PMID:
21323623
3.

Accuracy and clinical utility of a point-of-care HbA1c testing device.

Knaebel J, Irvin BR, Xie CZ.

Postgrad Med. 2013 May;125(3):91-8. doi: 10.3810/pgm.2013.05.2664.

PMID:
23748510
4.

Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study.

Tamborlane WV, Kollman C, Steffes MW, Ruedy KJ, Dongyuan X, Beck RW, Chase P, Fox LA, Wilson DM, Tsalikian E; Diabetes Research in Children Network (DirecNet) Study Group..

Pediatr Diabetes. 2005 Mar;6(1):13-6.

PMID:
15787896
5.
6.

Accuracy and precision of the Axis-Shield Afinion hemoglobin A1c measurement device.

Wood JR, Kaminski BM, Kollman C, Beck RW, Hall CA, Yun JP, Cengiz E, Haller MJ, Hassan K, Klingensmith GJ, Tamborlane WV.

J Diabetes Sci Technol. 2012 Mar 1;6(2):380-6.

7.

Comparison of IFCC-calibrated HbA(1c) from laboratory and point of care testing systems.

Manley SE, Hikin LJ, Round RA, Manning PW, Luzio SD, Dunseath GJ, Nightingale PG, Stratton IM, Cramb R, Sikaris KA, Gough SC, Webber J.

Diabetes Res Clin Pract. 2014 Sep;105(3):364-72. doi: 10.1016/j.diabres.2014.05.003. Epub 2014 May 23.

PMID:
24985893
8.

Hemoglobin A1c point-of-care assays; a new world with a lot of consequences!

Lenters-Westra E, Slingerland RJ.

J Diabetes Sci Technol. 2009 May 1;3(3):418-23.

9.

Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria.

Lenters-Westra E, Slingerland RJ.

Clin Chem. 2010 Jan;56(1):44-52. doi: 10.1373/clinchem.2009.130641. Epub 2009 Nov 19.

10.

Standardization of HbA1c value and its comparison to immunoassay--two years of experience.

Shiba T, Yano M, Maehata E, Kiyose H, Kotaki Y, Fukuzawa N, Hagura R.

Diabetes Res Clin Pract. 1996 May;32(3):175-82.

PMID:
8858206
11.

Rapid HbA1c testing in a community setting.

Carter JS, Houston CA, Gilliland SS, Perez GE, Owen CL, Pathak DR, Little RR.

Diabetes Care. 1996 Jul;19(7):764-7.

PMID:
8799636
12.

Performances of capillary electrophoresis and HPLC methods in HbA1c determination: diagnostic accuracy in HbS and HbD-Iran variants' presence.

Dessi M, Pieri M, Pignalosa S, Martino FG, Zenobi R.

J Clin Lab Anal. 2015 Jan;29(1):57-60. doi: 10.1002/jcla.21728. Epub 2014 Mar 28.

PMID:
24687307
13.

Three of 7 hemoglobin A1c point-of-care instruments do not meet generally accepted analytical performance criteria.

Lenters-Westra E, Slingerland RJ.

Clin Chem. 2014 Aug;60(8):1062-72. doi: 10.1373/clinchem.2014.224311. Epub 2014 May 27.

14.

Analytic bias among certified methods for the measurement of hemoglobin A1c: a cause for concern?

Holmes EW, Erşahin C, Augustine GJ, Charnogursky GA, Gryzbac M, Murrell JV, McKenna KM, Nabhan F, Kahn SE.

Am J Clin Pathol. 2008 Apr;129(4):540-7. doi: 10.1309/U3GPPTCBP1VLL8AW.

PMID:
18343780
15.

Can the Afinion HbA1c Point-of-Care instrument be an alternative method for the Tosoh G8 in the case of Hb-Tacoma?

Lenters-Westra E, Strunk A, Campbell P, Slingerland RJ.

Scand J Clin Lab Invest. 2017 Feb;77(1):2-7. Epub 2016 May 18.

PMID:
27191339
16.

Comparison between a rapid glycohaemoglobin (HbA1c) immunoassay and other indices of glycaemic control.

Le Marois E, Bruzzo F, Reach G, Guyon F, Luo J, Boillot J, Slama G, Selam JL.

Acta Diabetol. 1996 Sep;33(3):232-5.

PMID:
8904931
17.

The effect of elevated fetal hemoglobin on hemoglobin A1c results: five common hemoglobin A1c methods compared with the IFCC reference method.

Rohlfing CL, Connolly SM, England JD, Hanson SE, Moellering CM, Bachelder JR, Little RR.

Am J Clin Pathol. 2008 May;129(5):811-4. doi: 10.1309/YFVTUD0GHJF7D16H.

PMID:
18426743
18.

Analytical performance of the Axis-Shield Afinion for hemoglobin A1c measurement: impact of lot number.

Dupuy AM, Badiou S, Elong-Bertard C, Bargnoux AS, Cristol JP.

Clin Lab. 2014;60(3):369-76.

PMID:
24697111
19.

Point-of-care testing of HbA1C is traceable to IFCC reference method by external calibration.

Zhou R, Tong Q, Zuo C, Song ZX, Ma HA, Yue YH, Zhang R, Wang QT.

Clin Chim Acta. 2014 Jun 10;433:249-53. doi: 10.1016/j.cca.2014.03.010. Epub 2014 Mar 25.

PMID:
24675057
20.

Interference of common haemoglobin variants with the Tosoh G7 standard mode HbA1c method.

Piehler AP, Grimholt RM, Bjerner J, Buchmann MS.

Scand J Clin Lab Invest. 2015 Sep;75(5):362-6. doi: 10.3109/00365513.2015.1031687. Epub 2015 Apr 10.

PMID:
25858015

Supplemental Content

Support Center